Date: 2016-08-22
Type of information: Opening of new premises
Compound:
Company: XBiotech (USA - TX)
Therapeutic area:
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On August 22, 2016, XBiotech announced the timing for the grand opening of its state-of-the-art commercial manufacturing facility. The nearly 40,000 square foot facility is on XBiotech’s own 48-acre location just 15 minutes from the Texas capital in Austin. The building will provide a significant increase in the company’s manufacturing and quality operations in anticipation of commercialization of the Company’s product pipeline.
- The new facility will increase about ten-fold the Company’s current production capacity. Completion of this building is the first phase in the Company’s plan to develop the 48-acre property to house additional production facilities, laboratories and administrative operations, creating a headquarter campus as the center of its global operations.
Financial terms:
Latest news:
Is general: Yes
